RT Journal
A1 Rensing KL, Kastelein JP, Twickler M
T1 IS insulin the preferred compound in lowering glucose levels in patients after a myocardial infarction?
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2009
FD September 28
VO 169
IS 17
SP 1633
OP 1638
DO 10.1001/archinternmed.2009.326
UL http://dx.doi.org/10.1001/archinternmed.2009.326
AB 

			Looking at their interesting observations, we wonder whether insulin should be used as the preferable compound to lower glucose levels. From Figure 2 of their article,1 the in-hospital mortality appeared to be more pronounced in patients who were treated with insulin (although not significant) compared with non–insulin-treated patients. This trend was present along almost all glucose level intervals. Therefore, these results might suggest a less beneficial outcome in those hyperglycemic patients treated with insulin.